Apr. 18 2024
Source Page: Public Sector Equality Duty report 2022/23Found: .............................................................................. 16 ‘Working Through Cancer
Apr. 18 2024
Source Page: The Smart Data Roadmap: action the government is taking in 2024 to 2025Found: A recent study, funded by Cancer Research UK found that analysis of loyalty card data , from two UK
Written Evidence Apr. 18 2024
Inquiry: The Office for Local GovernmentFound: In the medical context, research covers a cohort of known positives, eg having had a positive cancer
Asked by: Luke Evans (Conservative - Bosworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to support women with a genetic history of breast cancer to access screening services in (a) England and (b) Leicestershire.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
In Leicestershire and nationwide, women with a very high risk (VHR) of breast cancer due to family history may be offered screening earlier and more often, as part of the NHS Breast Screening Programme.
Women formally identified as eligible for VHR breast screening are referred to the National Health Service breast screening service associated with their general practice. They are eligible to be screened from the age of 25 years old upwards, and should be invited every year. The diagnostic screen includes mammography or magnetic resonance imaging, depending on age and risk criteria, and is therefore not the same as the routine breast screening service. To support screening of VHR women, a new central database is planned to ensure all referrals reach NHS breast screening services.
Asked by: Peter Gibson (Conservative - Darlington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of providing lymphaticovenous anastomosis surgery on the NHS.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
No formal assessment has been made of the potential merits of providing lymphaticovenous anastomosis surgery on the National Health Service. On 16 April 2024, the National Institute for Health and Care Excellence (NICE) published interventional procedures guidance that states that lymphovenous anastomosis during axillary dissection for preventing secondary lymphoedema in adults with breast cancer, can be used in the NHS while more evidence is generated, and that it can only be used with special arrangements for clinical governance, consent and audit, or research. The NICE’s interventional procedures guidance makes recommendations for the NHS on whether procedures are sufficiently safe and efficacious for use in routine clinical practice.
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment her Department has made of the adequacy of bowel cancer diagnosis services in (a) Stockport and (b) Greater Manchester.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department continues to take steps to improve early diagnosis for all cancers, which encompasses bowel cancer, and in all areas, including Stockport and Greater Manchester. The Department is working jointly with NHS England on implementing the Delivery Plan for Tackling the COVID-19 Backlog of Elective Care, which includes plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer diagnosis and treatment.
NHS England is working to meet the Faster Diagnosis Standard (FDS), which sets a target of 28 days from urgent referral by a general practitioner or screening programme to patients being told that they have cancer, or that cancer is ruled out. To achieve this target, NHS England has: streamlined bowel cancer pathways by implementing faecal immunochemical testing (FIT) triage for patients in primary and secondary care settings; implemented non-symptom specific pathways for patients; and opened community diagnostic centres across England, prioritising this capacity for cancer services. The latest published data from February 2024 shows FDS performance was 78.1% nationally. More specifically to bowel cancer, the latest published data shows that at a national level, the number of people diagnosed with bowel cancer has risen to 41,596 in 2021, compared to 37,702 diagnosed in 2019. Since the FIT kit was introduced into the bowel cancer screening programme in April 2019, national uptake has increased from 59.2% to 67.8%. the latest data for the North-West region shows that 64.3% of 60 to 74-year-olds completed their bowel screening in the first quarter of 2023/24.
In 2023 the NHS England’s Help Us Help You campaign urged people to take up the offer of bowel screening when invited, and the screening offer for the bowel screening programme is being gradually extended from age 60 down to 50 years old by 2025, ensuring more people are screened and potentially diagnosed with bowel cancer at the earliest stage. NHS England is also now offering routine preventative bowel cancer screening to people with Lynch syndrome, with 94% of people on average receiving the test between 2021 and 2023, up from 47% in 2019.
Asked by: Margaret Greenwood (Labour - Wirral West)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, what information his Department provided between 1 September 2023 and 23 February 2024 to people who wished to apply for a lump sum payment under the Pneumoconiosis etc. (Workers’ Compensation) Act 1979 who had (a) been awarded Industrial Injuries Disablement Benefit as they had unilateral but not bilateral Pleural Thickening, PD9 and (b) been awarded Industrial Injuries Disablement Benefit for asbestos-related lung cancer based on their employment history but had not been diagnosed with asbestosis, PD8A.
Answered by Mims Davies - Parliamentary Under-Secretary (Department for Work and Pensions)
Regulations which widened potential Pneumoconiosis etc. (Workers’ Compensation) Act 1979 scheme entitlement to include sufferers of unilateral diffuse pleural thickening and asbestos-related primary carcinoma of the lung (without asbestosis) came into force on 23 February 2024. Once the Department identified that these customers were not previously entitled to an award under the Pneumoconiosis etc. (Workers’ Compensation) Act 1979 scheme, the Department’s priority was to amend the relevant legislation as quickly as possible.
An initial letter was sent on 09 January 2024 notifying asbestos support groups of the situation, and the Department’s intention to amend the legislation, and a follow-up letter was sent to asbestos support groups on 26 February 2024, confirming that the new regulations had now come into force.
Eligible customers should receive award notifications as usual when their claim is processed.